‘Mental clarity’ supplement recalled | New data on SDD after PCI | FDA clears diabetes tech | Stroke on plane leads to lawsuit

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately. 

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

According to a new wrongful death lawsuit, members of the flight crew failed to pick up on a man's stroke symptoms, resulting in significant care delays. His family is now suing for damages in excess of $50,000.

Financial literacy is no longer optional for physicians. “If you're not financially viable, you can't function,” explained Nirat Beohar, MD. “The business education is probably just as important as learning a new procedure.”

The FTC argued that the $945M deal, first announced in 2024, was "anticompetitive." A federal judge agreed. 

Silintan is a dietary supplement marketed as a treatment for joint and body aches. According to a recent analysis by the FDA, however, all lots contained undeclared meloxicam, creating an increased risk of adverse events.

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.

RSNA is looking for a replacement for Suhny Abbara, MD, who is now the editor-in-chief of its flagship journal.

Herbert D. Aronow, MD, reviewed the many ways the reimbursement landscape is changing thanks to new Medicare policies. “This is a really exciting time in the renal denervation space," he said. 

In 2024, a Denver cardiologist was sentenced to 158 years to life in prison for drugging and sexually assaulting multiple women he met through online dating apps. Six of his victims have now filed a civil lawsuit that claims the apps are “hospitable to serial predators.”

The new guidance, published in JACC, focuses on three classes of commonly used anticancer therapies.

Over the first two years of implementation, about 7.5 million Medicaid enrollees eligible for cancer screenings will lose coverage, researchers estimate.  

Less than two years after closing its patient care clinics and selling its telehealth services, Walmart is re-entering healthcare with a new platform to match patients with virtual providers.